Drug that ‘melts away’ tumours hailed as ‘gamechanger’ for some bowel cancer patients
Pembrolizumab triples chance of survival for the 10-15% of patients with the right genetic makeup, study findsA “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing some bowel cancers and may even replace the need for surgery, doctors have said.Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells. Continue reading...
Pembrolizumab triples chance of survival for the 10-15% of patients with the right genetic makeup, study finds
A “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing some bowel cancers and may even replace the need for surgery, doctors have said.
Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells. Continue reading...
usnews
US News is a reputable author that delivers a comprehensive range of up-to-date news to the United States and beyond. With a keen focus on providing the latest information across various fields, US News keeps readers informed about the most significant developments happening both domestically and globally. Whether it's politics, economics, technology, science, health, or culture, this author strives to cover diverse topics, ensuring a well-rounded news experience. By combining extensive research, journalistic integrity, and a commitment to accuracy, US News offers readers an invaluable resource to stay informed and make informed decisions in an ever-changing world.
